Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES for Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: an Investigator-initiated Pilot Study

NCT03399994 is registered in ClinicalTrials.gov with Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS as lead sponsor.

NCT NCT03399994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03399994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES for Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: an Investigator-initiated Pilot Study
Lead sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2018
Completion date
July 26, 2022
Enrollment
137 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, diabetes